Sonrgy, Inc., a biotechnology company developing focused drug delivery technologies, has announced that it has entered into an exclusive license agreement with the University of California for the company's core technology, an ultrasound sensitive drug delivery platform.
Anasys Instruments reports on the publication in Nature Photonics from Prof. Belkin (The University of Texas at Austin) demonstrating the use of resonance-enhanced AFM-IR with unprecedented sensitivity.
The BiO Assay, a magnetic 3D bioprinting system being marketed and developed by Rainbow Coral Corp. and joint venture partner Nano3D Biosciences, is the first designed specifically for rapid, high-volume drug screening.
The financing, received from a strategic corporate partner and existing investors, will fund the completion of development, registration clinical trials, and commercial launch of the Company's mobile diagnostic platform and initial assays.
Using carbon nanotube technology, this new generation of monitors combines total combustible gas (TGS), temperature and load monitoring readings to provide real-time notification for single and three phase distribution transformers.
The research has the potential to transform the aerospace industry, as it seeks to adapt resins already widely used by aeronautical manufacturers and operators, utilizing nanotechnology to turn secondary structural composites into self-healing materials.
Graphene 3D Lab has reached a significant milestone by filing a provisional patent application for the use of graphene-enhanced material, along with other materials, in 3D Printing (Additive Manufacturing).